364 related articles for article (PubMed ID: 30347326)
1. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
[TBL] [Abstract][Full Text] [Related]
2. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance.
Yu L; Ren R; Li S; Zhang C; Chen C; Lv H; Zou Z; Pei X; Song Z; Zhang P; Wang H; Yang G
Eur J Med Chem; 2024 Jun; 272():116466. PubMed ID: 38704938
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of ocotillol derivatives fused with 2-aminothiazole via A-ring as modulators of P-glycoprotein-mediated multidrug resistance.
Wang Y; Zhang D; Ma G; Su Z; Liu M; Wang R; Meng Q; Bi Y; Wang H
Eur J Med Chem; 2022 Dec; 243():114784. PubMed ID: 36167009
[TBL] [Abstract][Full Text] [Related]
4. Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance.
Guo M; Ren Q; Wang B; Ji W; Ni J; Feng Y; Bi Y; Tian J; Wang H
Eur J Med Chem; 2019 Nov; 182():111668. PubMed ID: 31505451
[TBL] [Abstract][Full Text] [Related]
5. Pyxinol bearing amino acid residues: Easily achievable and promising modulators of P-glycoprotein-mediated multidrug resistance.
Wang C; Gao M; Liu S; Zou Z; Ren R; Zhang C; Xie H; Sun J; Qi Y; Qu Q; Song Z; Yang G; Wang H
Eur J Med Chem; 2021 Apr; 216():113317. PubMed ID: 33706147
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Pyxinol Amide Derivatives Bearing Amino Acid Residues as Nonsubstrate Allosteric Inhibitors of P-Glycoprotein-Mediated Multidrug Resistance.
Yang G; Liu S; Zhang C; Yu L; Zou Z; Wang C; Gao M; Li S; Ma Y; Xu R; Song Z; Liu R; Wang H
J Med Chem; 2023 Jul; 66(13):8628-8642. PubMed ID: 37332162
[TBL] [Abstract][Full Text] [Related]
8. Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
Fong WF; Shen XL; Globisch C; Wiese M; Chen GY; Zhu GY; Yu ZL; Tse AK; Hu YJ
Bioorg Med Chem; 2008 Apr; 16(7):3694-703. PubMed ID: 18313307
[TBL] [Abstract][Full Text] [Related]
9. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
Jansson PJ; Yamagishi T; Arvind A; Seebacher N; Gutierrez E; Stacy A; Maleki S; Sharp D; Sahni S; Richardson DR
J Biol Chem; 2015 Apr; 290(15):9588-603. PubMed ID: 25720491
[TBL] [Abstract][Full Text] [Related]
10. Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents.
Zhu J; Wang R; Lou L; Li W; Tang G; Bu X; Yin S
J Med Chem; 2016 Jul; 59(13):6353-69. PubMed ID: 27328029
[TBL] [Abstract][Full Text] [Related]
11. Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoprotein.
Cao X; Li R; Xiong H; Su J; Guo C; An T; Zong H; Zhao R
Eur J Med Chem; 2021 Oct; 221():113520. PubMed ID: 34029775
[TBL] [Abstract][Full Text] [Related]
12. 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers.
Braconi L; Bartolucci G; Contino M; Chiaramonte N; Giampietro R; Manetti D; Perrone MG; Romanelli MN; Colabufo NA; Riganti C; Dei S; Teodori E
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):974-992. PubMed ID: 32253945
[TBL] [Abstract][Full Text] [Related]
13. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
Wang X; Ren QW; Liu XX; Yang YT; Wang BH; Zhai R; Qi JG; Tian JW; Wang HB; Bi Y
Eur J Med Chem; 2019 Jan; 161():364-377. PubMed ID: 30384042
[TBL] [Abstract][Full Text] [Related]
15. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication.
Munagala S; Sirasani G; Kokkonda P; Phadke M; Krynetskaia N; Lu P; Sharom FJ; Chaudhury S; Abdulhameed MD; Tawa G; Wallqvist A; Martinez R; Childers W; Abou-Gharbia M; Krynetskiy E; Andrade RB
Bioorg Med Chem; 2014 Feb; 22(3):1148-55. PubMed ID: 24405813
[TBL] [Abstract][Full Text] [Related]
17. 3'-O, 4'-O-aromatic acyl substituted 7,8-pyranocoumarins: a new class of P-glycoprotein modulators.
Shen X; Chen G; Zhu G; Cai J; Wang L; Hu Y; Fong WF
J Pharm Pharmacol; 2012 Jan; 64(1):90-100. PubMed ID: 22150676
[TBL] [Abstract][Full Text] [Related]
18. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
[TBL] [Abstract][Full Text] [Related]
19. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
Kim MK; Kim Y; Choo H; Chong Y
Bioorg Med Chem; 2017 Feb; 25(3):1219-1226. PubMed ID: 28043777
[TBL] [Abstract][Full Text] [Related]
20. Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents.
Zhang YK; Zhang H; Zhang GN; Wang YJ; Kathawala RJ; Si R; Patel BA; Xu J; Chen ZS
Oncotarget; 2015 Sep; 6(27):24277-90. PubMed ID: 26296969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
